Catena Biosciences was founded in 2020 based on technology developed in the Francis and Doudna Labs at UC Berkeley. Our platform allows for the rapid coupling of proteins for the creation of novel therapeutics in oncology, autoimmune disorders, and vaccine development. Follow our journey! www.catenabiosciences.com
| Website | http://catenabio.com |
| Employees | 19 (10 on RocketReach) |
| Founded | 2020 |
| Industry | Biotechnology Research |
| Keywords | Novel Therapeutics, Biopharmaceutical Development, Drug Development, Therapeutic Proteins, Drug Discovery Platform, Pharmaceutical Research, Oncology Therapeutics, Biotechnology Platform, Therapeutic Development, Biologics, Biotechnology, Autoimmune Therapies, Immunotherapy, Protein Engineering, Cancer Treatment, Precision Medicine, Molecular Engineering, Life Sciences, Medicine |
| Competitors | Agilent Technologies, Illumina, Novozymes, Zymergen, Inc., Amyris, bluebird bio, LanzaTech, Codexis, Inc., Arzeda, Geno +41 more (view full list) |
Looking for a particular CatenaBio employee's phone or email?
Marco Lobba is the Co-Founder and CEO of CatenaBio.
10 people are employed at CatenaBio.
CatenaBio is based in Berkeley, California.